HPLC + MS
Independently tested for identity and purity
KLOW-80MG-B01
May 8, 2026
99.75%
View Certificate of Analysis
Components BPC-157 · GHK-Cu · TB-500 · KPV
Net Quantity 80 mg / vial
Form Lyophilized Powder
10 mg
Blend Component
50 mg
Blend Component
10 mg
Blend Component
10 mg
Blend Component
KLOW Blend is a multi-peptide research compound supplied by NexPept as a lyophilized powder. Each vial contains four synthetic peptide components totalling 80 mg — BPC-157 (10 mg), GHK-Cu (50 mg), TB-500 (10 mg), and KPV (10 mg) — for use in in vitro laboratory research settings. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Compound Profile
Component breakdown — amounts, class, form, analytical method
Component breakdown — amounts, class, form, analytical method
| Property | Value |
|---|---|
| Product Name | KLOW Blend |
| Compound Class | Multi-component synthetic peptide blend |
| Components | BPC-157 (10 mg) · GHK-Cu (50 mg) · TB-500 (10 mg) · KPV (10 mg) |
| Net Quantity | 80 mg / vial (total) |
| Physical Form | Lyophilized powder |
| Analytical Method | High-Performance Liquid Chromatography (HPLC) + Mass Spectrometry (MS) |
| Appearance | White to off-white lyophilized solid |
In Vitro Research Context
Component pharmacology — laboratory use only
Component pharmacology — laboratory use only
10 mg
A synthetic pentadecapeptide studied in experimental laboratory models for cellular signalling and molecular interaction research.
50 mg
A copper-binding tripeptide complex (Gly-His-Lys) researched for peptide–ion interaction and cellular signalling models.
10 mg
A synthetic peptide fragment of Thymosin Beta-4 explored in structural and cytoskeletal research applications in vitro.
10 mg
A short-chain tripeptide (Lys-Pro-Val) fragment examined in peptide signalling and molecular interaction studies.
KLOW Blend is investigated in laboratory settings as a multi-peptide tool compound for research involving combined peptide signalling pathway studies, structure–function analysis of peptide blends, and experimental molecular and cellular research frameworks.
Research context: All four components are investigational synthetic peptides studied exclusively in preclinical in vitro settings. None of the components in this blend have been authorized by Health Canada for human or veterinary use.
Available Formats
80mg total — lyophilized powder
80mg total — lyophilized powder
| Format | Per-Component Amounts | Total / Form |
|---|---|---|
| KLOW Blend 80mg | BPC-157 10mg · GHK-Cu 50mg · TB-500 10mg · KPV 10mg | 80 mg / vial — lyophilized powder |
Supplied as a pre-blended lyophilized powder. Selection of quantity for use should be based on your specific in vitro research protocol as determined by qualified research personnel.
Laboratory Storage
Controlled storage conditions for lyophilized material
Controlled storage conditions for lyophilized material
Store sealed lyophilized material under controlled laboratory conditions in accordance with validated institutional SOPs and applicable technical documentation. Protect from light and moisture. Handling conditions should be established by qualified research personnel in accordance with the specific experimental protocol.
Note: No preparation, reconstitution, or administration instructions are provided. This compound is supplied for in vitro laboratory research use only. All handling must be conducted by qualified personnel following institutional safety protocols.
Research Literature
Scientific references & related resources
Scientific references & related resources
KLOW Blend Research Peptide Overview — NexPept compound overview and in vitro research context
PubMed — BPC-157 — peer-reviewed scientific literature
PubMed — Thymosin Beta-4 Fragment — peer-reviewed scientific literature
What Are Research Peptides? — peptide classification and in vitro research context
This product is supplied exclusively for in vitro laboratory and non-clinical research use by qualified research personnel. It is not authorized by Health Canada for human or veterinary use. No therapeutic, clinical, or health claims are made.
This material must not be administered to humans or animals. No dosage, preparation, reconstitution, or administration instructions are provided or implied. All handling and use must be conducted by qualified personnel in accordance with applicable institutional policies and legal requirements.
Be the first to review “KLOW Blend 80mg”
Related products
Reviews
There are no reviews yet.